766 related articles for article (PubMed ID: 16899107)
1. Interleukin-6 and chronic inflammation.
Gabay C
Arthritis Res Ther; 2006; 8 Suppl 2(Suppl 2):S3. PubMed ID: 16899107
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapeutic implication of IL-6 blockade.
Tanaka T; Kishimoto T
Immunotherapy; 2012 Jan; 4(1):87-105. PubMed ID: 22150003
[TBL] [Abstract][Full Text] [Related]
3. Structure-guided optimization of the interleukin-6 trans-signaling antagonist sgp130.
Tenhumberg S; Waetzig GH; Chalaris A; Rabe B; Seegert D; Scheller J; Rose-John S; Grötzinger J
J Biol Chem; 2008 Oct; 283(40):27200-7. PubMed ID: 18650419
[TBL] [Abstract][Full Text] [Related]
4. The IL-6-soluble IL-6Ralpha autocrine loop of endothelial activation as an intermediate between acute and chronic inflammation: an experimental model involving thrombin.
Marin V; Montero-Julian FA; Grès S; Boulay V; Bongrand P; Farnarier C; Kaplanski G
J Immunol; 2001 Sep; 167(6):3435-42. PubMed ID: 11544336
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-6 and its receptors: a highly regulated and dynamic system.
Wolf J; Rose-John S; Garbers C
Cytokine; 2014 Nov; 70(1):11-20. PubMed ID: 24986424
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic targets in rheumatoid arthritis: the interleukin-6 receptor.
Dayer JM; Choy E
Rheumatology (Oxford); 2010 Jan; 49(1):15-24. PubMed ID: 19854855
[TBL] [Abstract][Full Text] [Related]
7. The role of IL-6 trans-signaling in vascular leakage: implications for ovarian hyperstimulation syndrome in a murine model.
Wei LH; Chou CH; Chen MW; Rose-John S; Kuo ML; Chen SU; Yang YS
J Clin Endocrinol Metab; 2013 Mar; 98(3):E472-84. PubMed ID: 23348396
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-6 as a key player in systemic inflammation and joint destruction.
Fonseca JE; Santos MJ; Canhão H; Choy E
Autoimmun Rev; 2009 Jun; 8(7):538-42. PubMed ID: 19189867
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer.
Rose-John S; Scheller J; Elson G; Jones SA
J Leukoc Biol; 2006 Aug; 80(2):227-36. PubMed ID: 16707558
[TBL] [Abstract][Full Text] [Related]
10. Blockade of IL-6 Trans signaling attenuates pulmonary fibrosis.
Le TT; Karmouty-Quintana H; Melicoff E; Le TT; Weng T; Chen NY; Pedroza M; Zhou Y; Davies J; Philip K; Molina J; Luo F; George AT; Garcia-Morales LJ; Bunge RR; Bruckner BA; Loebe M; Seethamraju H; Agarwal SK; Blackburn MR
J Immunol; 2014 Oct; 193(7):3755-68. PubMed ID: 25172494
[TBL] [Abstract][Full Text] [Related]
11. CD14 is an acute-phase protein.
Bas S; Gauthier BR; Spenato U; Stingelin S; Gabay C
J Immunol; 2004 Apr; 172(7):4470-9. PubMed ID: 15034063
[TBL] [Abstract][Full Text] [Related]
12. The soluble Interleukin 6 receptor: generation and role in inflammation and cancer.
Chalaris A; Garbers C; Rabe B; Rose-John S; Scheller J
Eur J Cell Biol; 2011; 90(6-7):484-94. PubMed ID: 21145125
[TBL] [Abstract][Full Text] [Related]
13. Targeting Interleukin-6 Signaling in Clinic.
Kang S; Tanaka T; Narazaki M; Kishimoto T
Immunity; 2019 Apr; 50(4):1007-1023. PubMed ID: 30995492
[TBL] [Abstract][Full Text] [Related]
14. The role and therapeutic targeting of IL-6 in rheumatoid arthritis.
Narazaki M; Tanaka T; Kishimoto T
Expert Rev Clin Immunol; 2017 Jun; 13(6):535-551. PubMed ID: 28494214
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-6: Biology, signaling and strategies of blockade.
Schaper F; Rose-John S
Cytokine Growth Factor Rev; 2015 Oct; 26(5):475-87. PubMed ID: 26189695
[TBL] [Abstract][Full Text] [Related]
16. [The role of IL-6/sIL-6R complex and its natural inhibitor sgp130 in modulation of inflammatory process].
Augustyniak D; Majkowska-Skrobek G; Basiewicz-Worsztynowicz B; Jankowski A
Postepy Biochem; 2006; 52(2):194-203. PubMed ID: 17078509
[TBL] [Abstract][Full Text] [Related]
17. Cutting edge: trans-signaling via the soluble IL-6R abrogates the induction of FoxP3 in naive CD4+CD25 T cells.
Dominitzki S; Fantini MC; Neufert C; Nikolaev A; Galle PR; Scheller J; Monteleone G; Rose-John S; Neurath MF; Becker C
J Immunol; 2007 Aug; 179(4):2041-5. PubMed ID: 17675459
[TBL] [Abstract][Full Text] [Related]
18. IL-6/IL-6 receptor system and its role in physiological and pathological conditions.
Mihara M; Hashizume M; Yoshida H; Suzuki M; Shiina M
Clin Sci (Lond); 2012 Feb; 122(4):143-59. PubMed ID: 22029668
[TBL] [Abstract][Full Text] [Related]
19. IL-6 transsignaling: the in vivo consequences.
Jones SA; Richards PJ; Scheller J; Rose-John S
J Interferon Cytokine Res; 2005 May; 25(5):241-53. PubMed ID: 15871661
[TBL] [Abstract][Full Text] [Related]
20. IGF-1R signalling contributes to IL-6 production and T cell dependent inflammation in rheumatoid arthritis.
Erlandsson MC; Töyrä Silfverswärd S; Nadali M; Turkkila M; Svensson MND; Jonsson IM; Andersson KME; Bokarewa MI
Biochim Biophys Acta Mol Basis Dis; 2017 Sep; 1863(9):2158-2170. PubMed ID: 28583713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
